The present invention provides a crystal that has excellent oral absorption and can be obtained with particularly good reproducibility. Provided is a (R)-N-(1-(3-(cyclopentyloxy)phenyl)ethyl)-3-((2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl)methoxy)propane-1-sulfonamide crystal.